Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells

References

• ABE, K. I., INouE, 0. and YUMIOKA, E., 1990, Biliary excretion of metabolites of baicalin and baicalein in rats. Chemical and Pharmaceutical Bulletin, 38, 2 08–211.
   Google Scholar
• AMP, A., BOUCHON, I., SIEST, G. and SABOLOVIC, N., 1995, Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyltransfera 1*6. Biochemical Pharmacology, 50, 557–561.
   PubMed Web of Science ®Google Scholar
• BARANCZYK-KUZMA, A., GARREN, J. A., HIDALGO, I. J. and BORCHARDT, R. T., 1991, Substrate specificity and some properties of phenol sulfotransfera from human intestinal Caco-2 cells. Life Sciences, 49, 1197–1206.
   Google Scholar
• BJORGE S., HAMELEHLE, K. L., HOMAN, R., ROSE, S. E., TURLUCK, D. A. and WRIGHT, D. S., 1991, Evidence for glucuronide conjugation of p-nitrophenol in the Caco-2 cell model. Pharmaceutical Research, 8, 1441–1443.
   Google Scholar
• BOULTON, D. W., WALLE, U. K. and WALLE, T., 1999, Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism. Journal of Pharmacy and Pharmacology 51, 353–359.
   PubMed Web of Science ®Google Scholar
• BOUTIN, J. A., MEUNIER, F., LAMBERT, P. H., HENNIG, P., BERTIN, D., SERKIZ, B. and VOLLAND, J. P., 1993, In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats. Drug Metabolism and Disposition, 21, 1157–1166.
   PubMed Web of Science ®Google Scholar
• CAMPBELL, N. R. C., VAN LOON, J. A. and WErNsHmEoum, R. M., 1987, Human liver phenol sulfotransfera: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochemical Pharmacology, 36, 1435–1446.
   Google Scholar
• CHIKHALE, P. J. and BORCHARDT, R. T., 1994, Metabolism of L-a-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers - comparison with metabolism in vivo. Drug Metabolism and Disposition, 22, 592–600.
   PubMed Web of Science ®Google Scholar
• CIOLEVO, H. P., DASCHNER, P. J., WANG, T. T. Y. and YEH, G. C., 1998, Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochemical Pharmacology, 56, 197–206.
   Google Scholar
• COMER, K. A. and FALANY C. N., 1992, Immunological characterization of dehydroepiandrosterone sulfotransfera from human liver and adrenal. Molecular Pharmacology, 41, 645–651.
   Google Scholar
• CRITCHFIELD, J. W., BuTERA, S. T. and FOLKS, T. M., 1996, Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Research and Human Retroviruses, 12, 39–46.
   PubMed Web of Science ®Google Scholar
• CRITCHFIELD, J. W., COLIGAN, J. E., FOLKS, T. M. and BuTERA, S. T., 1997, Casein kinase II is a selective target of HIV-1 transcriptional inhibitors. Proceedings of the National Academy of Sciences, USA, 94, 6110–6115.
   PubMed Web of Science ®Google Scholar
• FAIANY C. N., WHEELER, J., OH, T. S. and FALANY J. L., 1994, Steroid sulfation by expressed human cytosolic sulphotransf erases. Journal of Steroid Biochemistry and Molecular Biology, 48, 369–375.
   Google Scholar
• GANGULY, T. C., KRASNYKH, V. and FALANY C. N., 1995, Bacterial expression and kinetic characterization of the human monoamine-sulfating form of phenol sulfotransferase. Drug Metabolism and Disposition, 23, 945–950.
   Google Scholar
• GREEN, M. D., KING, C. D., MOJARRABI, B., MACKENZIE, P. I. and TEPHLY, T. R., 1998, Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransfera 1A3. Drug Metabolism and Disposition, 26, 507–512.
   PubMed Web of Science ®Google Scholar
• GREEN, M. D., OTURU, E. M. and TEPHLY, T. R., 1994, Stable expression of a human liver UDP-glucuronosyltransfera (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metabolism and Disposition, 22, 799–805.
   PubMed Web of Science ®Google Scholar
• HARTMAN, A. P., WILSON, A. A., WILSON, H. M., ABER G., FALANY C. N. and WALLE, T., 1998, Enantioselective sulfation of J3-receptor agonists by the human intestine and the recombinant M-form phenolsulfotransferase Chirality, 10, 800–803.
   Google Scholar
• HERTOG, M. G. L., HOLLMAN, P. C. H. and KATAN, M. B., 1992, Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Journal of Agricultural and Food Chemistry, 40,2379–2383.
   Google Scholar
• HERTOG, M. G. L., HOLLMAN, P. C. H. and VAN DE PuTTE, B., 1993, Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. Journal of Agricultural and Food Chemistry, 41, 1242–1246.
   Google Scholar
• JÄGER, W., ZEMBSCH, B., WOLSCHANN, P., PITTENAUER, E., SENDEROWICZ, A. M., SAUSVILLE, E. A., SEDLACEK, H. H., GRAF, J. and THALHAMMER, T., 1998, Metabolism of the anticancer drug flavopiridol, anew inhibitor of cyclin dependent kinases, in rat liver. Life Sciences, 62,1861–1873.
   Google Scholar
• KELI SO., HERTOG, M. G. L., FESKENS, E. J. M. and KROMHOUT, D., 1996, Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Archives of Internal Medicine, 156, 637–642.
   Google Scholar
• KNEKT, P., PavrNEN, R., REUNANEN, A. and MAATELA J., 1996, Flavonoid intake and coronary mortality in Finland: a cohort study. British Medical Journal, 312, 478–481.
   Google Scholar
• KITINAU, J., 1976, The flavonoids. A class of semi-essential food components: their role in human nutrition. World Review of Nutrition and Dietetics, 24, 117–191.
   PubMedGoogle Scholar
• LEPLEY, D. M. and PELLING, J. C., 1997, Induction of p21/WAF1 and GI cell-cycle arrest by the chemopreventive agent apigenin. Molecular Carcinogenesis, 19, 74–82.
   PubMed Web of Science ®Google Scholar
• LEWIS, A. J., KELLY, M. M., WALLE, U. K., EATON, E. A., FALANY C. N. and WALLE, T., 1996, Improved bacterial expression of the human P form phenolsulfotransfera - applications to drug metabolism. Drug Metabolism and Disposition, 24, 1180–1185.
   Google Scholar
• LI, W., HARPER, P. A., TANG, B. K. and OKEY A. B., 1998, Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells - CYP1A2 expression in the L5180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene. Bio-chemical Pharmacology, 56, 599–612.
   Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FAR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MABRY, T. J., MARKHAM, K. R. and THOMAS, M. B., 1970, chapter V-3. The UV spectra of flavones and flavonols in the presence of Na0Ac. In The Systematic Identification of Flavonoids (New York: Springer), pp. 48–49.
   Google Scholar
• MANACH C., MORAND C., CRESPY V., DEMIGNE', C., TEXIER, 0., REGERAT, F. and 12Lvd SY, C., 1998, Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Letters, 426, 331–336.
   Google Scholar
• MCMILLAN, J. M. and JoLLow, D. J., 1992, Galactosamine hepatotoxicity: effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicology and Applied Pharmacology, 115, 234–240.
   PubMed Web of Science ®Google Scholar
• MEUNIER, V., BouRRd, M., BERGER, Y. and FABRE, G., 1995, The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biology and Toxicology, 11, 187–194.
   PubMed Web of Science ®Google Scholar
• MOON, J. Y., LEE, D. W. and PARK, K. H., 1998, Inhibition of 7-ethoxycoumarin 0-deethylase activity in rat liver microsomes by naturally occurring flavonoids: structure-activity relationships. Xenobiotica, 28, 117–126.
   PubMed Web of Science ®Google Scholar
• MTNZEL, P. A., BOOKJANS, G., MEHNER, G., LEHnixd STER T. and BOCK, K. W., 1996, Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyl-transfera UGT1A6. Archives of Biochemistry and Biophysics, 335, 205–210.
   Google Scholar
• MIJNZEL, P. A., LEHMK(5 STER, T., BRUCK, M., RrnER, J. K. and BOCK, K. W., 1998, Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransfera UGT1A6. Archives of Biochemistry and Biophysics, 350, 72–78.
   Google Scholar
• NIELSEN, S. E., BREINHOLT V., JUSTESEN, U., CORNETT, C. and DRAGSTED, L. 0., 1998, In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotka, 28, 389401.
   Google Scholar
• OLDHAM, J. W., CASCIANO, D. A. and CAVE, M. D., 1980, Comparative induction of unscheduled DNA synthesis by physical and chemical agents in non-proliferating primary cultures of rat hepatocytes. Chemico-Biological Interactions, 29, 303–314.
   PubMed Web of Science ®Google Scholar
• PETERS, W. H. M., KocK, L., NAGENGAST, F. M. and KREMERS, P. G., 1991, Biotransformation enzymes in human intestine: critical low levels in the colon? Gut, 32, 408–412.
   Google Scholar
• PRUEKSARITANONT, T., GORHAM, L. M., HOCHMAN, J. H., TRAN, L. 0. and VYAS, K. P., 1996, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metabolism and Disposition, 24, 634–642.
   Google Scholar
• SERGENT-ENGELEN, T., DELISTRIE, V. and SCHNEIDER, Y. J., 1993, Phase I and II biotransformations in living Caco-2 cells cultivated under serum-free conditions - selective apical excretion of reaction products. Biochemical Pharmacology, 46, 1393–1401.
   PubMed Web of Science ®Google Scholar
• SHEVIAMURA, H., Suzum, H., HANANO M., SUZUKI, A. and SUGIYAMA, Y., 1993, Identification of tissues responsible for the conjugative metabolism of liquiritigenin in rats: an analysis based on metabolite kinetics. Biological and Pharmaceutical Bulletin, 16, 899–907.
   Google Scholar
• SIBS, M. H., LE BON, A. M., CANIVENC -LAVIER, M. C., AMIOT, M. J., SABATIER S., ALBERT, S. Y. and SUSCHETET M., 1996, Flavonoids of honey and propolis: Characterization and effects on hepatic drug-metabolizing enzymes and benzo[a]pyrene-DNA binding in rats. Journal of Agricultural and Food Chemistry 44, 2297–2301.
   Google Scholar
• STEINER, A., WALLE, U. K. and WALLE, T., 1992, Induction of propranolol metabolism in the Hep G2 human hepatoma cell line. Journal of Pharmacy and Pharmacology, 44, 611–614.
   PubMed Web of Science ®Google Scholar
• STRASSBURG, C. P., MANNS, M. P. and TUKEY, R. H., 1998, Expression of the UDP-glucuronosyl-transfera 1A locus in human colon - identification and characterization of the novel extrahepatic UGT1A8. Journal of Biological Chemistry, 273, 8719–8726.
   PubMed Web of Science ®Google Scholar
• STRASSBURG C. P., NGUYEN, N., MANNS, M. P. and TUKEY, R. H. 1999, UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology, 116, 149–160.
   PubMed Web of Science ®Google Scholar
• SUNDARAM, R. S., SZUMLANSKI C., OTTERNESS, D., VAN LOON, J. A. and WErNsintsoum, R. M., 1989, Human intestinal phenol sulfotransfera: assay conditions, activity levels and partial puri-fication of the thermolabile form. Drug Metabolism and Disposition, 17, 255–264.
   Google Scholar
• TSYRLOV, I. B., MIKHAILENKO, V. M. and GELBOIN, H. V., 1994, Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-45 Osto different flavonoids. Biochimica et Biophysica Acta, 1205, 325–335.
   PubMed Web of Science ®Google Scholar
• VARIN, L., BARRON, D. and IBRAHIM, R. K., 1987, Enzymatic assay for flavonoid sulfotransferase. Analytical Biochemistry, 161, 176–180.
   PubMed Web of Science ®Google Scholar
• WALGREN, R. A., WALLE, U. K. and WALLE, T., 1998, Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochemical Pharmacology, 55, 1721–1727.
   PubMed Web of Science ®Google Scholar
• WALLE, T., EATON, E. A. and WALLE, U. K., 1995, Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase Biochemical Pharmacology, 50, 731–734.
   Google Scholar
• WALLE, T., WALLE, U. K., SHWED, J. A., THORNBURG, K. R., MATH[s, C. E. and PESOLA, G. R., 1994, Human phenolsulfotransferases : chiral substrates and expression in Hep G2 cells. Chemico-Biological Interactions, 92, 47–55.
   Google Scholar
• WALLE, T., WALLE, U. K., THORNBURG, K. R. and SCHEY, K. L., 1993, Stereoselective sulfation of albuterol in humans - biosynthesis of the sulfate conjugate by Hep G2 cells. Drug Metabolism and Disposition, 21, 76–80.
   PubMed Web of Science ®Google Scholar
• WALLE, U. K., GALIJATOVIC, A. and WALLE, T., 1999, Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochemical Pharmacology, 58, 431438.
   Web of Science ®Google Scholar
• WEBER, G., SHEN, F., PRAJDA, N., YEH, Y. A., YANG, H., HERENYIOVA, M. and LOOK, K. Y. 1996, Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Research, 16, 3271–3282.
   PubMed Web of Science ®Google Scholar
• Wu, D., RAMIN, S. A. and CEDERBAUM, A. I., 1997, Effect of pyridine on the expression of cytochrome P450 isozymes in primary rat hepatocyte culture. Molecular and Cellular Biochemistry, 173, 103–111.
   PubMed Web of Science ®Google Scholar
• Zliu, B. T., EZELL, E. L. and LIEHR, J. G., 1994, Catechol-0-methyltransferase-catalyze1 rapid 0-methylation of mutagenic flavonoids: metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. Journal of Biological Chemistry, 269, 292–299.
   PubMed Web of Science ®Google Scholar